1 / 6

Antiparasitic Drugs Market

Global Antiparasitic Drugs Market size and share is currently valued at USD 25.08 billion in 2024 and is anticipated to generate an estimated revenue of USD 38.20 billion by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 5.4% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2024 - 2032<br>

alicedesouza
Download Presentation

Antiparasitic Drugs Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Antiparasitic Drugs Market Expected to Reach USD 38.20 Billion by 2032 by 2032 | CAGR: 5.4% Antiparasitic Drugs Market Share, Size, Trends, Industry Analysis Report, By Type (Antiprotozoals, Anthelmintics, Others); By Route of Administration; By Distribution Channel; By Region; Segment Forecast, 2024- 2032

  2. Antiparasitic Drugs Market Estimate & Forecast • Global Antiparasitic Drugs Market size and share is currently valued at USD 25.08 billion in 2024 and is anticipated to generate an estimated revenue of USD 38.20 billion by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 5.4% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2024 – 2032 • The antiparasitic drugs market focuses on medications used to treat parasitic infections caused by organisms like protozoa, helminths, and ectoparasites. Key drivers include the prevalence of parasitic diseases, particularly in tropical and developing regions, and rising awareness of parasitic infections in livestock and companion animals. The market encompasses drugs such as antimalarials, anthelmintics, and ectoparasiticides used in human and veterinary medicine. Increasing investments in drug development, combined with government initiatives to control parasitic diseases, fuel market growth. The market is also seeing opportunities from advancements in biotechnology and growing demand for novel treatments due to drug resistance.

  3. Antiparasitic Drugs Market Trends And Opportunity The antiparasitic drugs market is witnessing several key trends and opportunities: Rising Prevalence of Parasitic Infections: Increased global awareness of diseases like malaria, leishmaniasis, and schistosomiasis is driving demand for effective treatments, particularly in tropical and developing regions. Drug Resistance Concerns: Growing resistance to existing antiparasitic drugs, such as chloroquine for malaria, is fueling the need for novel therapies and research into new drug classes. Advancements in Biotechnology: Innovations like gene editing and RNA interference are opening new avenues for developing targeted antiparasitic treatments, improving drug efficacy and safety. Increased Focus on Veterinary Health: The livestock industry and companion animal care are boosting demand for veterinary antiparasitic drugs, with rising awareness of zoonotic diseases that can spread to humans. Government and NGO Initiatives: Global health programs from organizations like the WHO and Gates Foundation are supporting the eradication of parasitic diseases, creating opportunities for market expansion. Pharmaceutical Partnerships: Collaborations between pharmaceutical companies and research institutions are accelerating drug development, offering growth opportunities through innovative products and faster regulatory approvals.

  4. Antiparasitic Drugs Market Competitive Landscape • The study then includes the competitive insights of market across various regions wherein our research analysts explores in-depth profiles of main players along with new product launches, recent technologies influencing the target market. The competitive study section also contains production, major development strategies, revenue, and growth rate for the leading players. This assessment will aid market players to stay ahead of competitive landscape and boost productivity. Major players operating in the market are: • AstraZeneca • Bayer AG • Cipla Limited • Dr. Reddy's Laboratories • F. Hoffmann-La Roche Ltd. • GlaxoSmithKline • Ipca Laboratories Ltd • Lupin Pharmaceuticals • Merck & Co. • Novartis • Pfizer • Sanofi • Sun Pharmaceutical Industries Ltd. • Viatris • Zydus Group • Browse Complete Report

  5. About Us Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for a clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors, and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and highly qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. Web:www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com

  6. Thank You! Thank You! • Polaris Market Research30 Wall Street8th Floor, New York City, NY 10005,United States sales@polarismarketresearch.com +1-929 297-9727

More Related